Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.

Elvin Kedhi,Marc Gomes,Bo Lagerqvist,J. Gustav Smith,Elmir Omerovic,Stefan James,Jan Harnek,Göran Olivecrona

Clinical impact of second-generation everolimus-eluting stent compared with first-generation drug-eluting stents in diabetes mellitus patients: insights from a nationwide coronary intervention register.

2012

Elvin Kedhi
Marc Gomes
Bo Lagerqvist
J. Gustav Smith
Elmir Omerovic
Stefan James
Jan Harnek
Göran Olivecrona

OBJECTIVES: This study sought to study the second-generation everolimus-eluting stent (EES) as compared with first-generation sirolimus-eluting (SES) and paclitaxel-eluting stents (PES) in diabetes ...

Keywords:

Radiology
Internal medicine
Cardiology
Restenosis
Medicine
Stent
Everolimus
Diabetes mellitus
Angioplasty
Confidence interval
Percutaneous coronary intervention
Hazard ratio
Coronary artery disease
Conventional PCI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations